Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Travis W. Ott
03.26.24 -- FDA's 2024 Regulatory Outlook Recap
Stem cells are the backbone of many allogeneic therapies and where they come from affects development and supply chain logistics, particularly cryopreservation. What temperatures are ideal to maintain product potency? How do you build a reliable cold chain? How do you work with existing infrastructure to allow for an “off-the-shelf” therapy? Don’t miss the next Cell & Gene Live digital event! Registration is free thanks to the support of Charter Medical and Bio-Techne.
08.10.23 -- Genetic Tuning's Impact On Genetic Medicine
Get more Cell & Gene insight with our FREE newsletter Newsletter | August 10, 2023 By Heidi Zhang, Ph.D., Tune Therapeutics Epigenome editing, or genetic tuning, is an innovative molecular technology that fine-tunes the expression of genes to a therapeutically appropriate dosage, effectively expanding the reach of genetic medicine beyond the binary on-and-off switches of prior methods.
08.09.22 -- Why Gene Therapy is a Game Changer for High Unmet Medical Needs
Article | By Travis Ott, Invetech Current supply chains support distinct automated CGT manufacturing elements when they are well-characterized and integrated into commercial manufacturing. As cell therapies develop and become more commercialized, manufacturers must adopt a sophisticated supply chain that provides the necessary materials and technologies to support therapeutic development.
02.17.22 -- A Summary of CGT Market Outlook Report
Article | By Travis Ott, Invetech How to navigate global supply chain challenges to help avoid cell therapy manufacturing production bottlenecks this year. Article | By Robert L. Roy, IPS-Integrated Project Services Effective vaccine production facility planning combines technological innovation, streamlined workflows, and savvy budget management to ensure project speedbumps don’t become roadblocks.
07.06.21 -- Is FDA Cracking Down Too Hard On CMC For Gene Therapy?
Newsletter | July 6, 2021 By Geoff MacKay, AVROBIO When it comes to chemistry, manufacturing, and controls (CMC), is the FDA cracking down on the industry more harshly than expected? By Erin Harris, editor in chief, Cell & Gene Eric David, M.D., J.D., CEO at BridgeBio Gene Therapy, discusses the company’s long-term strategy as well as manufacturing expectations for BBP-631.
Travis W. Ott of Chambersburg - The Shippensburg News-Chronicle: Obituaries
He worked for both the Cumberland Highway Family Restaurant and Baker’s Kwik Stop, Orrstown. Travis was a 2005 graduate of the Shippensburg Area Senior High School. In addition to his parents, he is survived by his brother, Kenneth E. Ott Jr. and his wife Jenna of Shippensburg; a sister, Nicole L. Baker of Chambersburg; grandparents, John and Marinda Dunlap and Gladys Ott; two nieces, Abby and Emma Neil, all of Shippensburg; and numerous aunts, uncles and cousins.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Travis W.
Contact Travis W., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack